Andreas (Andy) S. Bommarius is a professor of Chemical and Biomolecular Engineering as well of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, GA.  He received his diploma in Chemistry in 1984 at the Technical University of Munich, Germany and his Chemical Engineering B.S. and Ph.D. degrees in 1982 and 1989 at MIT, Cambridge, MA.

From 1990-2000, he led the Laboratory of Enzyme Catalysis at Degussa (now Evonik) in Wolfgang, Germany, where his work ranged from immobilizing homogenous catalysts in membrane reactors to large-scale cofactor-regenerated redox reactions to pharma intermediates.

At Georgia Tech since 2000, his research interests cover green chemistry and biomolecular engineering, specifically biocatalyst development and protein stability studies.  His lab applies data-driven protein engineering to improve protein properties on catalysts ranging from ene and nitro reductases to cellobiohydrolases.  Bommarius has guided the repositioning of the curriculum towards Chemical and Biomolecular Engineering by developing new courses in Process Design, Biocatalysis and Metabolic Engineering, as well as Drug Design, Development, and Delivery (D4), an interdisciplinary course with Mark Prausnitz.

Andy Bommarius in 2008 became a Fellow of the American Institute of Medical and Biological Engineering.  Since 2010, he is Director of the NSF-I/UCR Center for Pharmaceutical Development (CPD), a Center focusing on process development, drug substance and product stability, and novel analytical methods for the characterization of drug substances and excipients.

Sam Brown's lab studies the multi-scale dynamics of infectious disease. Their goal is to improve the treatment and control of infectious diseases through a multi-scale understanding of microbial interactions. Their approach is highly interdisciplinary, combining theory and experiment, evolution, ecology and molecular microbiology in order to understand and control the multi-scale dynamics of bacteria pathogens.

Faces of Research - Profile Article

Joe Lachance is an Assistant Professor in the School of Biological Sciences at Georgia Institute of Technology and a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.

Lachance received his Ph.D. in Genetics from Stony Brook University in Stony Brook, New York. He conducted his postdoctoral studies as a NIH Kirschstein postdoctoral fellow at the University of Pennsylvania.

Lachance's research is in the areas of human evolutionary genomics, population genetics, and health disparities. His lab integrates large genome-scale datasets with evolutionary theory and computer simulations. They have found evidence of ancient introgression in Africa, inferred that the leading edge of the out-of-Africa migration involved an excess of males, discovered that genetic risks of cancer have decreased over evolutionary time, and identified novel targets of positive selection.

Lynn Kamerlin received her Master of Natural Sciences from the University of Birmingham (UK), in 2002, where she remained to complete a PhD in Theoretical Organic Chemistry under the supervision of Dr. John Wilkie (awarded 2005). Subsequently, she was a postdoctoral researcher in the labs of Stefan Boresch at the University of Vienna (2005-2007), Arieh Warshel at the University of Southern California (2007-2009, Research Associate at the University of Southern California in 2010) and Researcher with Fahmi Himo (2010). She is currently a Professor and Georgia Research Alliance – Vasser Wooley Chair of Molecular Design at Georgia Tech, a Professor of Structural Biology at Uppsala University, a Fellow of the Royal Society of Chemistry. She has also been a Wallenberg Scholar, the recipient of an ERC Starting Independent Researcher Grant (2012-2017) and the Chair of the Young Academy of Europe (YAE) in 2014-2015. Her non-scientific interests include languages (fluent in 5), amateur photography and playing the piano.

Christopher E. Carr is an engineer/scientist with training in aero/astro, electrical engineering, medical physics, and molecular biology. At Georgia Tech he is an Assistant Professor in the Daniel Guggenheim School of Aerospace Engineering with a secondary appointment in the School of Earth and Atmospheric Sciences. He is a member of the Space Systems Design Lab (SSDL) and runs the Planetary eXploration Lab (PXL). He serves as the Principal Investigator (PI) or Science PI for several life detection instrument and/or astrobiology/space biology projects, and is broadly interested in searching for and expanding the presence of life beyond Earth while enabling a sustainable human future. He previously served as a Research Scientist at MIT in the Department of Earth, Atmospheric and Planetary Sciences and a Research Fellow at the Massachusetts General Hospital in the Department of Molecular Biology. He serves as a Scott M. Johnson Fellow in the U.S. Japan Leadership Program.

Saurabh Sinha received his Ph.D. in Computer Science from the University of Washington, Seattle, in 2002, and after post-doctoral work at the Rockefeller University with Eric Siggia, he joined the faculty of the University of Illinois, Urbana-Champaign, in 2005, where he held the positions of Founder Professor in Computer Science and Director of Computational Genomics in the Carl R. Woese Institute for Genomic Biology until 2022. He joined Georgia Institute of Technology in 2022, as Wallace H. Coulter Distinguished Chair in Biomedical Engineering, with joint appointments in Biomedical Engineering and Industrial & Systems Engineering. Sinha’s research is in the area of bioinformatics, with a focus on regulatory genomics and systems biology. Sinha is an NSF CAREER award recipient and has been funded by NIH, NSF and USDA. He co-directed an NIH BD2K Center of Excellence and was a thrust lead in the NSF AI Institute at UIUC. He led the educational program of the Mayo Clinic-University of Illinois Alliance, and co-led data science education for the Carle Illinois College of Medicine. Sinha has served as Program co-Chair of the annual RECOMB Regulatory and Systems Genomics conference and served on the Board of Directors for the International Society for Computational Biology (2018-2021). He was a recipient of the University Scholar award of the University of Illinois, and selected as a Fellow of the AIMBE in 2018.

Gaucher was guided in biochemistry by Peter Tipton and Bayesian Theory by George Smith. Gaucher subsequently earned his Ph.D. from the University of Florida under the tutelage of Steve Benner and Michael Miyamoto.[1] Gaucher received the Walter M. Fitch Award from the Society for Molecular Biology and Evolution for his graduate work.[2] He then did postdoctoral work with NASA's Astrobiology Institute in conjunction with a National Research Council Fellowship. After the two-year fellowship, Gaucher served as President of the Foundation for Applied Molecular Evolution.

Gaucher was hired as an Associate Professor by the Georgia Institute of Technology in 2008 [1][3][4] The Gaucher group conducts basic and applied research at the interface of molecular evolution and synthetic biology. As of February 2016, his h-index, as calculated by Google Scholar, is 25.[5]

Gaucher is also the founder and president of the early-stage biotechnology company General Genomics. His company exploits novel platforms to engineer proteins for the biomedical and industrial sectors.

After studying ecology as a biology major at Swarthmore College, Annalise Paaby learned fly pushing as a technician for Steve DiNardo and then discovered evolutionary genetics as a tech for Paul Schmidt. She joined Paul’s lab as a graduate student and earned her Ph.D. from the University of Pennsylvania in 2009. In 2015, Paaby completed her postdoctoral training with Matt Rockman at New York University and began her appointment at Georgia Tech.

Patrick McGrath's research group is interested in understanding the genetic basis of heritable behavioral variation. In the current age, it has become cheap and easy to catalog the set of genetic differences between two individuals. But which genetic differences are responsible for generating differences in innate behaviors, including liability to neurological diseases such as autism, bipolar disease, and schizophrenia? How do these causative genetic variants modify a nervous system? Besides their role in disease, genetic variation is the substrate for natural selection. To understand how behavior evolves, we must understand how it varies.